Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury

Abstract Our previous research developed a novel tuberculosis (TB) DNA vaccine ag85a/b that showed a significant therapeutic effect on the mouse tuberculosis model by intramuscular injection (IM) and electroporation (EP). However, the action mechanisms between these two vaccine immunization methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Nan Wang, Yan Liang, Qianqian Ma, Jie Mi, Yong Xue, Yourong Yang, Lan Wang, Xueqiong Wu
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.854
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850189147370684416
author Nan Wang
Yan Liang
Qianqian Ma
Jie Mi
Yong Xue
Yourong Yang
Lan Wang
Xueqiong Wu
author_facet Nan Wang
Yan Liang
Qianqian Ma
Jie Mi
Yong Xue
Yourong Yang
Lan Wang
Xueqiong Wu
author_sort Nan Wang
collection DOAJ
description Abstract Our previous research developed a novel tuberculosis (TB) DNA vaccine ag85a/b that showed a significant therapeutic effect on the mouse tuberculosis model by intramuscular injection (IM) and electroporation (EP). However, the action mechanisms between these two vaccine immunization methods remain unclear. In a previous study, 96 Mycobacterium tuberculosis (MTB) H37Rv‐infected BALB/c mice were treated with phosphate‐buffered saline, 10, 50, 100, and 200 μg ag85a/b DNA vaccine delivered by IM and EP three times at 2‐week intervals, respectively. In this study, peripheral blood mononuclear cells (PBMCs) from three mice in each group were isolated to extract total RNA. The gene expression profiles were analyzed using gene microarray technology to obtain differentially expressed (DE) genes. Finally, DE genes were validated by real‐time reverse transcription‐quantitive polymerase chain reaction and the GEO database. After MTB infection, most of the upregulated DE genes were related to the digestion and absorption of nutrients or neuroendocrine (such as Iapp, Scg2, Chga, Amy2a5), and most of the downregulated DE genes were related to cellular structural and functional proteins, especially the structure and function proteins of the alveolar epithelial cell (such as Sftpc, Sftpd, Pdpn). Most of the abnormally upregulated or downregulated DE genes in the TB model group were recovered in the 100 and 200 μg ag85a/b DNA IM groups and four DNA EP groups. The pancreatic secretion pathway downregulated and the Rap1 signal pathway upregulated had particularly significant changes during the immunotherapy of the ag85a/b DNA vaccine on the mouse TB model. The action targets and mechanisms of IM and EP are highly consistent. Tuberculosis infection causes rapid catabolism and slow anabolism in mice. For the first time, we found that the effective dose of the ag85a/b DNA vaccine immunized whether by IM or EP could significantly up‐regulate immune‐related pathways and recover the metabolic disorder and the injury caused by MTB.
format Article
id doaj-art-5076c20b3b424c24bd9e708046931433
institution OA Journals
issn 2050-4527
language English
publishDate 2023-05-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj-art-5076c20b3b424c24bd9e7080469314332025-08-20T02:15:41ZengWileyImmunity, Inflammation and Disease2050-45272023-05-01115n/an/a10.1002/iid3.854Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injuryNan Wang0Yan Liang1Qianqian Ma2Jie Mi3Yong Xue4Yourong Yang5Lan Wang6Xueqiong Wu7Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaTuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital PLA General Hospital Beijing ChinaAbstract Our previous research developed a novel tuberculosis (TB) DNA vaccine ag85a/b that showed a significant therapeutic effect on the mouse tuberculosis model by intramuscular injection (IM) and electroporation (EP). However, the action mechanisms between these two vaccine immunization methods remain unclear. In a previous study, 96 Mycobacterium tuberculosis (MTB) H37Rv‐infected BALB/c mice were treated with phosphate‐buffered saline, 10, 50, 100, and 200 μg ag85a/b DNA vaccine delivered by IM and EP three times at 2‐week intervals, respectively. In this study, peripheral blood mononuclear cells (PBMCs) from three mice in each group were isolated to extract total RNA. The gene expression profiles were analyzed using gene microarray technology to obtain differentially expressed (DE) genes. Finally, DE genes were validated by real‐time reverse transcription‐quantitive polymerase chain reaction and the GEO database. After MTB infection, most of the upregulated DE genes were related to the digestion and absorption of nutrients or neuroendocrine (such as Iapp, Scg2, Chga, Amy2a5), and most of the downregulated DE genes were related to cellular structural and functional proteins, especially the structure and function proteins of the alveolar epithelial cell (such as Sftpc, Sftpd, Pdpn). Most of the abnormally upregulated or downregulated DE genes in the TB model group were recovered in the 100 and 200 μg ag85a/b DNA IM groups and four DNA EP groups. The pancreatic secretion pathway downregulated and the Rap1 signal pathway upregulated had particularly significant changes during the immunotherapy of the ag85a/b DNA vaccine on the mouse TB model. The action targets and mechanisms of IM and EP are highly consistent. Tuberculosis infection causes rapid catabolism and slow anabolism in mice. For the first time, we found that the effective dose of the ag85a/b DNA vaccine immunized whether by IM or EP could significantly up‐regulate immune‐related pathways and recover the metabolic disorder and the injury caused by MTB.https://doi.org/10.1002/iid3.854ag85a/b DNADNA vaccineimmunotherapyMycobacterium tuberculosistranscriptome
spellingShingle Nan Wang
Yan Liang
Qianqian Ma
Jie Mi
Yong Xue
Yourong Yang
Lan Wang
Xueqiong Wu
Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
Immunity, Inflammation and Disease
ag85a/b DNA
DNA vaccine
immunotherapy
Mycobacterium tuberculosis
transcriptome
title Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
title_full Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
title_fullStr Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
title_full_unstemmed Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
title_short Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury
title_sort mechanisms of ag85a b dna vaccine conferred immunotherapy and recovery from mycobacterium tuberculosis induced injury
topic ag85a/b DNA
DNA vaccine
immunotherapy
Mycobacterium tuberculosis
transcriptome
url https://doi.org/10.1002/iid3.854
work_keys_str_mv AT nanwang mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT yanliang mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT qianqianma mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT jiemi mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT yongxue mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT yourongyang mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT lanwang mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury
AT xueqiongwu mechanismsofag85abdnavaccineconferredimmunotherapyandrecoveryfrommycobacteriumtuberculosisinducedinjury